Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose Prednisolone

NCT04744623 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Benign Mucous Membrane Pemphigoid

Interventions

DRUG: large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP

Sponsor

Tanta University